Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 May;27(5):689-93.
doi: 10.1007/s00467-012-2112-1. Epub 2012 Feb 23.

Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter?

Editorial

Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter?

Michael L Moritz. Pediatr Nephrol. 2012 May.

Abstract

The syndrome of inappropriate antidiudresis (SIAD) and cerebral salt wasting (CSW) are similar conditions with the main difference being the absence or presence of volume depletion. The two conditions may be indistinguishable at presentation, as volume status is difficult to assess, which can lead to under-diagnosis of CSW in patients with central nervous system (CNS) disease. Carefully conducted studies in patients with CNS disease have indicated that CSW may be more common than SIAD. CSW may be differentiated from SIAD based on the persistence of hypouricemia and increased fractional excretion of urate following the correction of hyponatremia. Hyponatremia should be prevented if possible and treated promptly when discovered in patients with CNS disease as even mild hyponatremia could lead to neurological deterioration. Fluid restriction should not be used for the prevention or treatment of hyponatremia in hospitalized patients with CNS disease as it could lead to volume depletion especially if CSW is present. 0.9% sodium chloride may not be sufficiently hypertonic for the prevention of hyponatremia in hospitalized patients with CNS disease and a more hypertonic fluid may be required. The preferred therapy for the treatment of hyponatremia in patients with CNS disease is 3% sodium chloride.

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. J Neurosurg Pediatr. 2011 Jun;7(6):609-15 - PubMed
    1. Clin J Am Soc Nephrol. 2009 Feb;4(2):309-15 - PubMed
    1. Am J Med. 1988 Mar;84(3 Pt 1):409-18 - PubMed
    1. Neurocrit Care. 2009;11(1):14-9 - PubMed
    1. Neurologist. 2003 Nov;9(6):290-300 - PubMed

LinkOut - more resources